癌症和XI因子缺乏症患者的静脉血栓塞栓症
Pavlina Chrysafi1, Andriy Derkach2, Vasiliki Xirou1
1Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Journal of thrombosis and haemostasis : JTH
|July 18, 2025
概括
缺乏XI因子可显著降低癌症患者静脉血栓栓塞 (VTE) 风险. 这一发现表明,FXI抑制可能是管理癌症高凝血能力的潜在策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 血栓形成研究研究
背景情况:
- 在一般人群中,XI因子 (FXI) 缺乏与较低的VTE风险和没有增加的出血有关.
- 正在研究与癌症相关的VTE的FXI抑制剂,但缺乏关于FXI抑制癌症高凝血能力的数据.
研究的目的:
- 为了确定与匹配的对照组相比,在患有FXI缺乏症的癌症患者中VTE的发生率.
- 调查FXI缺乏在癌症患者队列中修改静脉瘤风险方面的潜在作用.
主要方法:
- 纪念斯隆凯特林癌症中心的回顾性研究.
- 在患有FXI缺乏症的癌症患者中比较VTE发生率 (n=73) 与匹配的对照组 (n=185).
- 匹配标准包括年龄,性别,最近的手术,癌症类型/阶段和血液计数.
主要成果:
- 12个月累计VTE发病率在FXI缺乏患者中为4.1%,对照组为10.6% (P=0.052).
- 大型手术相关出血发生在12.9%的FXI缺乏患者中,而对照组为2.1%.
结论:
- 十一因子缺乏与癌症患者静脉瘤风险降低有关.
- 研究结果表明,FXI抑制可能是该人群中预防VTE的可行策略.
相关概念视频
Venous Thrombosis III: Interprofessional Care
23
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
23
Venous Thrombosis IV: Nursing Management
24
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
24
Pulmonary Embolism III: Nursing Management
42
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
42
Venous Thrombosis I: Introduction
42
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
42
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
913
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
913


